Should internal mammary chain (IMC) sentinel node biopsy be performed?. Outcome in 90 consecutive non-biopsied patients with a positive IMC scintigraphy

Breast

Volumn 17, Issue 2, 2008, Pages 152-158

  Wouters, M W J M ^a   van Geel, A N ^a   Menke Pluijmers, M ^a   de Kanter, A Y ^a   de Bruin, H G ^a   Verhoog, L ^a   Eggermont, A M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast carcinoma; Internal mammary chain; Lymph nodes; Sentinel lymph nodes; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; TECHNETIUM 99M;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DRUG INDICATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY CHAIN SCINTIGRAPHY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 41549137826     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.08.005     Document Type: Article

References (51)

1. Giuliano A.E., Dale P.S., Turner R.R., et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 3 (1995) 394-399
2. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
3. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer: a multicenter validation study. N Eng J Med (1998) 339-341
4. Uren R.F., Howman-Giles R.B., Thompson J.F., et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36 (1995) 1775-1780
5. Lamonica D., Edge S.B., Hurd T., et al. Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures. Clin Nucl Med 28 (2003) 558-564
6. Van der Ent F.W., Kengen R.A., van der Pol H.A., et al. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234 (2001) 79-84
7. Estourgie S.H., Nieweg O.E., Valdes Olmos R.A., et al. Lymphatic drainage patterns from the breast. Ann Surg 239 (2004) 232-237
8. Estourgie S.H., Tanis P.J., Nieweg O.E., et al. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 10 (2003) 935-941
9. Klauber-DeMore N., Van Zee K.J., Linkov I., et al. Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg 193 5 (2001) 547-555
10. Sugg S.L., Ferguson D.J., Posner M.C., et al. Should internal mammary nodes be sampled in the sentinel lymph node era?. Ann Surg Oncol 7 3 (2000) 188-192
11. Veronesi U., Marubini E., Mariani L., et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 35 9 (1999) 1320-1325
12. Lacour J., Le M.G., Hill C., et al. Is it useful to remove internal mammary nodes in operable breast cancer?. Eur J Surg Oncol 13 4 (1987) 309-314
13. Morimoto T., Monden Y., Takashima S., et al. Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer. Surg Today 24 (1994) 210-214
14. Meier P., Ferguson D.J., and Karrison T. A controlled trial of extended radical versus radical mastectomy. Ten-year results. Cancer 63 1 (1989) 188-195
15. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danisch Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
16. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
17. Whelan T.J., Julian J., Wright J., et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
18. Obedian E., and Hafty B.G. Internal mammary nodal irradiation in conservatively managed breast cancer patients: is there a benefit?. Int J Radiat Oncol Biol Phys 44 5 (1999) 997-1003
19. Freedman G.M., Fowble B.L., Nicolaou N., et al. Should internal mammary lymph nodes in breast cancer be the target for the radiation oncologist?. Int J Radiat Oncol Biol Phys 46 (2000) 805-814
20. Jatoi I. Internal mammary sentinel nodes in primary breast cancer. Curr Med Res Opin 19 (2003) 567-569
21. Fowble B., Hanlon A., Freedman G., et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 47 (2000) 883-894
22. Host H., Brennhovd I.O., and Loeb M. Postoperative radiotherapy in breast cancer, long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12 (1986) 717-720
23. Bevilacqua J.L., Gucciardo G., Cody H.S., et al. A selection algorithm for internal mammary sentinel lymphnode biopsy in breast cancer. Eur J Surg Oncol 28 (2002) 603-614
24. Cody H.S., and Urban J.A. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 2 (1995) 32-37
25. Noguchi M., Ohta N., and Thomas M. Risk of internal mammary lymph node metastasis and its prognostic value in breast cancer patients. J Surg Oncol 52 (1993) 26-30
26. Jansen L., Doting M.H.E., Rutgers E.J.Th., et al. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 87 (2000) 920-925
27. Galimberti V., Veronesi P., Arnone P., et al. Stage migration after biopsy of internal mammary chain lymphnodes in breast cancer patients. Ann Surg Oncol 9 (2002) 924-928
28. Noguchi M. Internal mammary sentinel node biopsy for breast cancer: is it practicable and relevant? (Review). Oncol Rep 9 3 (2002) 461-468
29. Hong J., Chog E., Soni N., et al. Extra-axillary sentinel node biopsy in the management of early breast cancer. Eur J Surg Oncol 31 9 (2005) 942-948
30. Kuenen-Boumeester V., Menke-Pluymers M., de Kanter A.Y., et al. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer 39 (2003) 170-174
31. Richtlijn Behandeling van het Mammacarcinoom (Guidelines for the treatment of breast cancer). Van Zuiden Communications BV, Alphen aan de Rijn, 2004, ISBN 90-76906-45-9.
32. Veronesi U., Zucali R., and Luini A. Local control and survival in early breast cancer: the Milan trial. Int J Radiat Oncol Biol Phys 12 (1986) 717-720
33. Palmer M.K., and Ribeiro G.G. Thirty-four year follow up of patients with breast cancer in clinical trial of postoperative radiotherapy. Br Med J 291 (1985) 1088-1091
34. Farrús B., Vidal-Sicart S., Velasco M., et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in radiotherapy plan. Int J Radiat Oncol Biol Phys 60 (2004) 715-721
35. Cranenbroek S., van der Sangen M.J., Kuijt G.P., et al. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat 89 3 (2005) 271-275
36. Veronesi U., Cascinelli N., Greco M., et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202 6 (1985) 702-707
37. Veronesi U., and Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 47 (1981) 170-175
38. Mansel R.E., Goyal A., and Newcombe R.G. Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer 5 4 (2004) 279-284
39. Early Breast Cancer Trialists' Collaborative Group (EBCTGC). Chemotherapy and hormonal therapy for early breast cancer: effects on recurrence and 15-year survival in an overview of the randomised trials. Lancet 2005.
40. Shimazu K., Tamaki Y., Taguchi T., et al. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg 237 (2003) 390-398
41. Krynyckyi B.R., Chun H., Kim H.H., et al. Factors affecting visualization of internal mammary sentinel nodes during lymphoscintigraphy. J Nucl Med 44 (2003) 1387-1393
42. Benda R.K., Cendan J.C., Copeland E.M., et al. Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification?. Cancer 100 (2004) 518-523
43. Lacour J., Bucalossi P., Cacers E., et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer 37 (1976) 206-214
44. Li K.Y., and Shen Z. An analysis of 1,242 cases of extended radical mastectomy. Breast Dis Breast 10 (1984) 10-19
45. Paredes P., Vidal-Sicart S., Zanon G., et al. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging 32 11 (2005) 1283-1287
46. Goyal A, Newcombe RG, Mansel RE, ALMANAC Trialists Group. Clinical relevance of internal mammary node drainage in sentinel node biopsy for breast cancer. Abstract 519: 2005 ASCO Annual Meeting at: 〈http://www.asco.org〉.
47. Lawson L.L., Sandler M., Martin W., et al. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer. Am Surg 70 (2004) 1050-1055
48. Dupont E., Cox C.E., Nguyen K., et al. Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol 8 10 (2001) 833-836
49. Johnson N., Soot L., Nelson J., et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg 179 5 (2000) 386-388
50. Noguchi M., Tsugawa K., and Miwa K. Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol 73 2 (2000) 75-80
51. Winchester D.J., Sener S.F., Winchester D.P., et al. Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients±efficacy of fitered Technetium 99m sulphur colloid with overnight migration time. J Am Coll Surg 188 6 (1999) 597-603